It is emerging that neovascularization in GBM is a complex, dynamic, and heterogeneous process, where the VEGF-mediated angiogenesis coexists with numerous non-canonical strategies, variously exploited by GBM to meet its ever-increasing metabolic demand, and differently involved in tumor progression, recurrence, and escape from treatments [8]. Here, VEGFA is linked to neoplasm.